Trial Summary
What is the purpose of this trial?The study will determine the efficacy of twice weekly hemodialysis in patients with residual kidney function.
Eligibility Criteria
This trial is for stable dialysis patients who can consent to participate. It's not for those who've used antibiotics in the last two months, expect to use them soon, were recently hospitalized, or have very low residual kidney function (<2.5 mL/min).Inclusion Criteria
Stable dialysis patients able to provide consent
Exclusion Criteria
You have taken antibiotics in the last two months or are expected to take them during the study.
You recently had a hospital stay or another event that made it hard for you to eat regularly.
Your kidneys are not working well, and filter less than 2.5 milliliters of fluid per minute.
Participant Groups
The study compares the effectiveness of hemodialysis twice a week versus the standard three times a week in patients who still have some kidney function left.
2Treatment groups
Experimental Treatment
Group I: Twice weekly hemodialysisExperimental Treatment1 Intervention
Participants will undergo hemodialysis twice per week.
Group II: Thrice weekly hemodialysisExperimental Treatment1 Intervention
Participants will undergo hemodialysis three times per week.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
VA Palo Alto Health Care SystemPalo Alto, CA
Santa Clara Valley Medical CenterSan Jose, CA
Satellite HealthCareSan Jose, CA
Loading ...
Who Is Running the Clinical Trial?
Palo Alto Veterans Institute for ResearchLead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator